Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ageas SA/NV stock logo
AGESY
ageas SA/NV
$46.59
-1.5%
$44.44
$37.91
$47.60
$8.76B0.715,310 shs1,645 shs
Disco Co. stock logo
DSCSY
Disco
$31.40
+1.2%
$33.92
$10.94
$38.73
$33.61B1.1249,693 shs37,087 shs
MonotaRO Co., Ltd. stock logo
MONOY
MonotaRO
$11.92
-3.2%
$11.13
$7.67
$15.48
$6.18B0.7257,460 shs29,885 shs
Nitto Denko Co. stock logo
NDEKY
Nitto Denko
$44.70
-1.6%
$46.30
$30.07
$48.58
$13.04B1.039,232 shs16,573 shs
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
$51.60
$51.60
$51.60
$51.98
N/A0.32N/AN/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ageas SA/NV stock logo
AGESY
ageas SA/NV
-1.48%+1.55%+2.53%+8.20%+6.43%
Disco Co. stock logo
DSCSY
Disco
+0.90%-8.48%-13.03%+18.34%+174.32%
MonotaRO Co., Ltd. stock logo
MONOY
MonotaRO
-3.25%-3.25%+0.85%+22.51%-15.64%
Nitto Denko Co. stock logo
NDEKY
Nitto Denko
-1.61%-1.07%-4.45%+14.06%+44.80%
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
0.00%0.00%0.00%0.00%+26.07%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ageas SA/NV stock logo
AGESY
ageas SA/NV
N/AN/AN/AN/AN/AN/AN/AN/A
Disco Co. stock logo
DSCSY
Disco
1.8677 of 5 stars
0.05.00.80.02.50.01.9
MonotaRO Co., Ltd. stock logo
MONOY
MonotaRO
1.0289 of 5 stars
0.03.01.70.00.60.02.5
Nitto Denko Co. stock logo
NDEKY
Nitto Denko
N/AN/AN/AN/AN/AN/AN/AN/A
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ageas SA/NV stock logo
AGESY
ageas SA/NV
2.20
HoldN/AN/A
Disco Co. stock logo
DSCSY
Disco
3.00
BuyN/AN/A
MonotaRO Co., Ltd. stock logo
MONOY
MonotaRO
N/AN/AN/AN/A
Nitto Denko Co. stock logo
NDEKY
Nitto Denko
N/AN/AN/AN/A
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
2.00
HoldN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ageas SA/NV stock logo
AGESY
ageas SA/NV
$10.94B0.80$10.33 per share4.51$47.94 per share0.97
Disco Co. stock logo
DSCSY
Disco
$2.15B15.84$0.65 per share47.99$2.38 per share13.19
MonotaRO Co., Ltd. stock logo
MONOY
MonotaRO
$1.81B3.30$0.38 per share31.57$1.23 per share9.69
Nitto Denko Co. stock logo
NDEKY
Nitto Denko
$6.88B1.87$4.31 per share10.37N/A
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
$1.95BN/A$3.06 per share16.86$7.90 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ageas SA/NV stock logo
AGESY
ageas SA/NV
$1.07BN/A0.006.130.34N/AN/AN/AN/A
Disco Co. stock logo
DSCSY
Disco
$613.40MN/A0.0046.18N/AN/AN/AN/AN/A
MonotaRO Co., Ltd. stock logo
MONOY
MonotaRO
$154.87M$0.3237.2531.37N/A8.59%27.56%18.55%N/A
Nitto Denko Co. stock logo
NDEKY
Nitto Denko
$807.88M$2.3219.2716.02N/A10.61%10.15%7.96%N/A
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
$329.08M$1.9326.7418.36N/A18.51%31.80%12.83%N/A

Latest AGESY, RCDTF, MONOY, DSCSY, and NDEKY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/2/2024Q4 2023
MonotaRO Co., Ltd. stock logo
MONOY
MonotaRO
N/A$0.09+$0.09$0.10N/A$454.15 million
1/26/2024Q3 2024
Nitto Denko Co. stock logo
NDEKY
Nitto Denko
N/A$0.89+$0.89$0.89N/A$1.66 billion

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ageas SA/NV stock logo
AGESY
ageas SA/NV
$2.234.79%N/AN/AN/A
Disco Co. stock logo
DSCSY
Disco
$0.070.22%N/AN/AN/A
MonotaRO Co., Ltd. stock logo
MONOY
MonotaRO
$0.060.50%N/A18.75%N/A
Nitto Denko Co. stock logo
NDEKY
Nitto Denko
$0.591.32%N/A25.43%N/A
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ageas SA/NV stock logo
AGESY
ageas SA/NV
N/AN/AN/A
Disco Co. stock logo
DSCSY
Disco
N/A
2.65
1.68
MonotaRO Co., Ltd. stock logo
MONOY
MonotaRO
0.01
2.04
1.53
Nitto Denko Co. stock logo
NDEKY
Nitto Denko
N/A
3.68
2.94
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
0.80
1.28
0.86

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
ageas SA/NV stock logo
AGESY
ageas SA/NV
44,230187.97 millionN/ANot Optionable
Disco Co. stock logo
DSCSY
Disco
4,5531.08 billionN/ANot Optionable
MonotaRO Co., Ltd. stock logo
MONOY
MonotaRO
1,375501.35 millionN/ANot Optionable
Nitto Denko Co. stock logo
NDEKY
Nitto Denko
26,070287.10 millionN/ANot Optionable
Recordati Industria Chimica e Farmaceutica S.p.A. stock logo
RCDTF
Recordati Industria Chimica e Farmaceutica
4,369N/AN/ANot Optionable

AGESY, RCDTF, MONOY, DSCSY, and NDEKY Headlines

SourceHeadline
Borsa: Milano fiacca con Recordati e Saipem, vola StmBorsa: Milano fiacca con Recordati e Saipem, vola Stm
msn.com - April 24 at 2:06 PM
Cvc Capital Partners al lavoro sul ‘dossier’ RecordatiCvc Capital Partners al lavoro sul ‘dossier’ Recordati
businesspeople.it - April 24 at 9:06 AM
Recordati scende in Borsa, spunti da analisti e mosse CVCRecordati scende in Borsa, spunti da analisti e mosse CVC
teleborsa.it - April 24 at 9:06 AM
CVC explores options for Italys Recordati, Bloomberg News reportsCVC explores options for Italy's Recordati, Bloomberg News reports
msn.com - April 23 at 6:03 PM
CVC Explores Options for €11 Billion Drugmaker RecordatiCVC Explores Options for €11 Billion Drugmaker Recordati
finance.yahoo.com - April 23 at 6:03 PM
UPDATE 1-CVC explores options for Italys Recordati, Bloomberg News reportsUPDATE 1-CVC explores options for Italy's Recordati, Bloomberg News reports
finance.yahoo.com - April 23 at 6:03 PM
Recordati, ricavi in aumento del 10,2% nel primo trimestreRecordati, ricavi in aumento del 10,2% nel primo trimestre
teleborsa.it - April 22 at 2:59 PM
Recordati: +10% ricavi I trim. a 607 mln, "forte inizio danno"Recordati: +10% ricavi I trim. a 607 mln, "forte inizio d'anno"
borsaitaliana.it - April 22 at 8:29 AM
Recordati, ok dei soci al bilancio e al dividendo. Landamento dei ricavi nel 1Q2024Recordati, ok dei soci al bilancio e al dividendo. L'andamento dei ricavi nel 1Q2024
soldionline.it - April 22 at 8:29 AM
Recordati, concluso il programma di buybackRecordati, concluso il programma di buyback
finanza.repubblica.it - April 11 at 6:02 PM
Recordati, azioni proprie all1,33% del capitale socialeRecordati, azioni proprie all'1,33% del capitale sociale
teleborsa.it - April 10 at 3:16 PM
Recordati in positivo dopo l’intervista al CEORecordati in positivo dopo l’intervista al CEO
trend-online.com - April 8 at 12:43 PM
Recordati, Investco detiene il 3,014%Recordati, Investco detiene il 3,014%
soldionline.it - March 22 at 6:51 AM
Azionario Italia: Recordati Dopo il Massimo Annuale Scende. OVS Resistenza a 3,25€Azionario Italia: Recordati Dopo il Massimo Annuale Scende. OVS Resistenza a 3,25€
fxempire.it - March 20 at 7:35 PM
Recordati, CdA approva bilancio 2023. Dividendo totale di 1,20 euroRecordati, CdA approva bilancio 2023. Dividendo totale di 1,20 euro
teleborsa.it - March 19 at 1:05 PM
Farmaceutica, le big si muovono: Astrazeneca acquista, Pfizer vende. Da Recordati cedola maggiorata con un occhio alle opportunitàFarmaceutica, le big si muovono: Astrazeneca acquista, Pfizer vende. Da Recordati cedola maggiorata con un occhio alle opportunità
msn.com - March 19 at 1:05 PM
Recordati: cda propone dividendo 1,20 per azione, di cui 0,57 gia pagati (RCO)Recordati: cda propone dividendo 1,20 per azione, di cui 0,57 gia' pagati (RCO)
borsa.corriere.it - March 19 at 8:05 AM
Recordati: positivo il superamento dei 53 euroRecordati: positivo il superamento dei 53 euro
milanofinanza.it - February 26 at 8:11 AM
Recordati ben intonato dopo i numeri 2023. Come è andata?Recordati ben intonato dopo i numeri 2023. Come è andata?
trend-online.com - February 25 at 10:26 AM
Le azioni Recordati non brillano dopo i conti, ma il futuro resta molto interessanteLe azioni Recordati non brillano dopo i conti, ma il futuro resta molto interessante
proiezionidiborsa.it - February 23 at 3:53 PM
Analisi Azionaria: STMicroelectronics Sotto Pressione, Recordati Verso nuovi MassimiAnalisi Azionaria: STMicroelectronics Sotto Pressione, Recordati Verso nuovi Massimi
fxempire.it - February 2 at 8:36 AM
Recordati, informativa sul buybackRecordati, informativa sul buyback
teleborsa.it - January 31 at 8:34 PM
Recordati: resistenza grafica a quota 51 euroRecordati: resistenza grafica a quota 51 euro
milanofinanza.it - January 30 at 8:47 AM
Recordati: il titolo allunga al rialzoRecordati: il titolo allunga al rialzo
milanofinanza.it - January 15 at 8:59 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

ageas SA/NV logo

ageas SA/NV

OTCMKTS:AGESY
ageas SA/NV, together with its subsidiaries, engages in insurance business in Europe and Asia. The company operates in five segments: Belgium, Europe, Asia, Reinsurance, and General Account. It primarily offers property, casualty, and life insurance products, as well as pension products; and reinsurance products. Its life insurance products include risks related to the life and death of individuals; and non-life insurance products comprise accident and health, motor, fire, and other insurance products, as well as other damages to property covering the risk of property losses or claims liabilities. The company serves private individuals, as well as small, medium-sized, and large companies through independent brokers and the bank channels. ageas SA/NV was founded in 1824 and is headquartered in Brussels, Belgium.
Disco logo

Disco

OTCMKTS:DSCSY
Disco Corporation manufactures and sells precision cutting, grinding, and polishing machines in Japan and internationally. Its precision machines include dicing saws, laser saws, grinders, polishers, wafer mounters, die separators, surface planers, and waterjet saws. The company also offers precision processing tools, such as dicing blades, grinding wheels, and dry polishing wheels; and other products, such as accessory equipment. In addition, it is involved in the disassembly and recycling of precision cutting, grinding, and polishing machines, as well as provides training services for the maintenance and operation of its products. Further, the company leases precision machines; and purchases and sells used machines. Additionally, it manufactures precision diamond abrasive tools, as well as offers chargeable processing services. The company was founded in 1937 and is headquartered in Tokyo, Japan.
MonotaRO logo

MonotaRO

OTCMKTS:MONOY
MonotaRO Co., Ltd., together with its subsidiaries, operates an online MRO products store in Japan and internationally. It offers products in various categories, such as safety protection equipment, work clothes, and safety shoes; logistics, storage, and packing supplies; tapes; safety supplies/safety signs; office supplies; office furniture/lighting/cleaning supplies; cutting tools/abrasives; measurement/surveying supplies; work/electric/pneumatic tools; spray/oil/grease/paint/adhesion/repair/welding supplies; and agricultural materials/gardening supplies. The company also provides building hardware products, building materials, and painting interior supplies; air conditioning/electrical equipment materials/electrical materials; piping/water supply/pump/pneumatic/hydraulic equipment/hose products; mechanical parts; control equipment/solder/static electricity countermeasure supplies; screws/bolts/nails/materials; car/truck supplies; motorcycle/bicycle supplies; kitchen equipment/kitchen products/store supplies; scientific research and development/clean room supplies; and medical/long-term care products. It serves factories, construction, automobile maintenance, and other industries. The company was formerly known as Sumisho Grainger Co., Ltd. and changed its name to MonotaRO Co., Ltd. in 2006. MonotaRO Co., Ltd. was founded in 2000 and is headquartered in Amagasaki, Japan. MonotaRO Co., Ltd. operates as a subsidiary of Grainger Global Holdings, Inc.
Nitto Denko logo

Nitto Denko

OTCMKTS:NDEKY
Nitto Denko Corporation primarily engages in the adhesive tapes business in Japan, the Americas, Europe, Asia, and Oceania. It provides double sided tapes, surface protective films, sealing materials, masking tapes, membranes, FPD/touch panel related products, gasket materials, semiconductor manufacturing process products, flexible printed circuit boards, porous films/breathable materials, and packaging tapes. The company also offers functional thermal transfer systems, such as labels, barcode label printers, and label printing software; tapes for electrical and electronic equipment; dust removal products for clean rooms; fluoroplastic sheets and tapes, and fluoroplastic porous films; and materials for housing and construction. In addition, it provides medical products, including transdermal therapeutic systems, athletic tapes, medical adhesive tapes for wearable devices and body sensors, adhesive tapes, and particles for nucleic acid synthesis. The company offers its products to automotive and transportation, housing/housing equipment, infrastructure, material, home appliance and electrical, display, electronic device, medical, packaging, and consumer/personal care industries. Nitto Denko Corporation was incorporated in 1918 and is headquartered in Osaka, Japan.
Recordati Industria Chimica e Farmaceutica logo

Recordati Industria Chimica e Farmaceutica

OTCMKTS:RCDTF
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis. The company also develops CARBAGLU for hyperammonemia due to NAGS deficiency; QARZIBA, an apeiron for the treatment of high-risk neuroblastoma patients with a partial response at the chemotherapeutical through myeloablative therapy and stem cell transplantation, and relapsed or refractory neuroblastoma. In addition, it offers SYLVANT for the treatment of idiopathic multicentric Castleman diseases; REAGILA for Schizophrenia; and ELIGARD for hormone-dependent prostate cancer, as well as CAPHOSOL, a medical device for treatment of oral mucositis due to chemo and radiation therapy. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.